PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Ovarian hyperstimulation syndrome (OHSS) is a problem that is sometimes seen in women who take fertility medicines that stimulate egg production.
Causes, incidence, and risk factors
Normally, a woman produces one egg per month. Some women who have trouble getting pregnant may be given medicines to help them make more eggs.
If these medicines stimulate the ovaries too much, the ovaries can become very swollen. Fluid can leak into the belly and chest area. This is called ovarian hyperstimulation syndrome (OHSS). OHSS occurs only after the eggs are released from the ovary (ovulation).
You may be more likely to get OHSS if:
- Your doctor gives you a shot of human chorionic gonadotropin (hCG)
- You get more than one dose of hCG after ovulation
- You become pregnant during this cycle
OHSS rarely occurs in women who only take fertility drugs by mouth.
OHSS affects up to 1 in 10 women who go through in vitro fertilization.
Other risk factors for OHSS include:
- Age younger than 35
- Very high estrogen level during fertility treatments
Symptoms
The symptoms of OHSS can range from mild to severe. Most women with the condition have mild symptoms such as:
- Abdominal bloating
- Mild pain in the abdomen
- Weight gain
In rare cases, women can have more serious symptoms, including:
- Significant weight gain (more than 10 pounds in 3 - 5 days)
- Severe pain or swelling in the belly area
- Decreased urination
- Shortness of breath
Signs and tests
If you have a severe case of OHSS, your health care provider will need to carefully monitor your symptoms. You may be admitted to the hospital.
Your weight and size of your belly area (abdomen) will be measured. Tests that may be done include:
- Abdominal ultrasound or vaginal ultrasound
- Chest x-ray
- Liver function test
- Tests to measure urine output
Treatment
Mild cases of OHSS usually don't need to be treated. You can ease your discomfort by doing the following:
- Get plenty of rest with your legs raised. This helps your body release the fluid. However, light activity every now and then is better than complete bed rest, unless your doctor tells you otherwise.
- Drink at least 10 - 12 glasses of fluid a day (especially drinks that contain electrolytes).
- Avoid alcohol or caffeinated beverages (such as colas or coffee).
- Avoid intense exercise and sexual intercourse, which can cause ovarian discomfort and may cause ovarian cysts to rupture or leak or cause the ovaries to twist and cut off blood flow (ovarian torsion).
- Take an over-the-counter pain reliever such as acetaminophen (Tylenol).
You should weigh yourself each day to make sure you are not putting on too much weight (5 or more pounds a day).
In the rare case that you develop severe OHSS, you will probably need to go to a hospital. The health care providers there will give you fluids through a vein (intravenous fluids), remove fluids that have collected in your body, and monitor your condition.
Expectations (prognosis)
Most mild cases of OHSS will go away on their own after menstruation starts. If you have a more severe case, it can take several days for symptoms to improve.
If you become pregnant during OHSS, the symptoms may get worse and can take weeks to go away.
Complications
In rare cases, OHSS can lead to life-threatening complications, including:
- Blood clots
- Kidney failure
- Severe electrolyte imbalance
- Severe fluid build-up in the abdomen or chest
Calling your health care provider
Call your health care provider if you experience any of the following symptoms:
- Decreased urination
- Dizziness
- Excessive weight gain (more than 5 pounds a day)
- Nausea so intense that you can't keep food or liquids down
- Severe abdominal pain
- Shortness of breath
Prevention
If you are receiving injections of fertility medicines, your doctor will monitor you carefully with blood tests and pelvic ultrasounds to make sure that your ovaries aren't over-responding.
If your estrogen level rises very high or very quickly while taking fertility injections, your risk for OHSS is increased. You may need to take a lower dose of the medicines or temporarily stop treatment.
Some women may be given a protein solution called albumin to reduce the chances of OHSS.
References
- Lobo RA. Infertility: etiology, diagnostic evaluation, management, prognosis. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier; 2007:chap 41.
- Schorge JO, Schaffer JI, Halvorson LM, et al. Treatment of the infertile couple. In: Cunningham FG, Leveno KL, Bloom SL, et al, eds. Williams Obstetrics. 23rd ed. New York, NY: McGraw-Hill; 2010:chap 20.
Review Date: 7/19/2012.
Reviewed by: Shehzad Topiwala, MD, Chief Consultant Endocrinologist, Premier Medical Associates, The Villages, FL. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Replacing FSH by hCG to complete follicular growth in women undergoing assisted reproduction
Follicle‐stimulating hormone (FSH) ‐ a relatively expensive drug ‐ is commonly used for several days to stimulate the ovaries of women undergoing assisted reproduction. Initial studies have shown that after a few days of using FSH to stimulate the ovaries, it can be replaced by human chorionic gonadotropin (hCG), which is less expensive. In addition to cost reduction, this intervention has a theoretical potential to reduce the risk of ovarian hyperstimulation syndrome (OHSS); though the underlying risk is already very low for most women. We searched the medical literature on in February 2013 for studies that evaluated the effectiveness and safety of using low‐dose hCG to replace FSH during the late follicular phase in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction, compared to the use of a conventional COH protocol. Five studies evaluating 351 women were included in this review. These studies were funded by fertility centres, universities, or both. We are very uncertain of the effect of this intervention on live birth, OHSS and miscarriage
The science behind screening testsScreening tests can lead to benefits and harms. Understand why, and how researchers find out if benefits outweigh harms for a test.
- Ovarian hyperstimulation syndromeOvarian hyperstimulation syndromePubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...